Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • DoP rejects...

DoP rejects application challenging NPPA price fixation order on Metoprolol

Farhat NasimWritten by Farhat Nasim Published On 2024-10-23T18:37:18+05:30  |  Updated On 23 Oct 2024 6:50 PM IST
Post-Patent Expiry Boom, Empagliflozin Sees Brand Flood, 147 Brands Launched: Pharmatrac
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: The Department of Pharmaceuticals (DoP) has rejected a review application filed by Ajanta Pharma against price fixation order issued by National Pharmaceutical Pricing Authority (NPPA) concerning Metoprolol Tablet 25mg and Metoprolol Tablet 50mg.

Ajanta Pharma filed the review plea under Para 31 of the Drugs (Prices Control) Order, 2013 against the order issued on 06.01.2023 by the NPPA. The order fixed the ceiling price of Metoprolol Tablet 25mg and Metoprolol Tablet 50mg.

Following the submission, the Department of Pharmaceuticals sought clarification from NPPA, leading to a hearing on June 1, 2023, where both parties presented their arguments.

Ajanta Pharma contended that NPPA has erred in determining the ceiling price of the said drug and hence may be directed to revise the same.

The drugmaker challenged the impugned notification in respect of ceiling price fixation of Metoprolol Tablet 25mg and Metoprolol Tablet 50mg issued by NPPA as improper, misconceived as it has been carried out erroneously, arbitrarily, without jurisdiction by NPPA, in mechanical manner with wrongful inclusion of formulations manufactured by the Applicant, namely Met XL 25mg Tablet ER 20 (Metoprolol 25mg Tablet Extended Release) and Met XL 50mg Tablet ER 20 (Metoprolol 50mg Tablet Extended Release) having modified dosage, incremental innovation and novel drug delivery system.

Ajanta submitted that it made representation to NPPA on December 8, 2022 within stipulated time against draft version displayed on its website on December 1, 2022, in respect of calculation of Metoprolol 25mg Tablet for wrongfully including formulation Met XL 25mg Tablet ER 20 (Metoprolol 25mg Tablet Extended Release) and Metoprolol 50mg tablet for wrongful inclusion of Met XL50 mg Tablet ER 20 (Metoprolol 50mg Tablet Extended Release), respectively, for ceiling price fixation under revised Schedule-I of DPCO, 2013 as the said formulations manufactured by the firm are distinct, separate and different and cannot be equated with the plain conventional Tablets.

Sl. no.

Name of formulation

Scheduled

Dosage form and

Strength

Unit

Ceiling Price in IQs.

8

Metoprolol

Modified Release Tablet 100 mg.

I Tablet

13.37

9

Metoprolol

Tablet 100 mg.

1 Tablet

9.93

Consequently, Metoprolol tablet in plain/ conventional dosage cannot be clubbed with modified release dosage as it would amount to be unreasonable, ultra vires, illegal, anomalous and not tenable.

Prior to aforesaid amendment of the DPCO, 2013 on 11 November 2022, earlier amendment in DPCO, 2013 was done via order dated 10th March 2016 in Schedule-I on the basis NLEM, 2015 wherein Metoprolol tablet was listed at item no, the petitioner mentioned in its submission.

Additionally, it pointed out that in existing aforesaid Schedule-I of the DPCO 2013, Metoprolol 25mg and Metoprolol 50mg plain tablets and sustained release tablets were specified separately and as under:

Schedule-I National List of Medicines (NLEM) 2015

Section 12- Cardiovascular Medicines

12.1 Medicine used in Angina

Medicine

Level of health care

Dosage form(s) and strength(s)

12.1.7

Metoprolol

P, S, T

Tablet 25mg

Tablet 50mg

SR Tablet 25mg

SR Tablet 50mg

It claimed that NPPA had notified separate ceiling prices of Metoprolol formulations plain/conventional tablets and modified dosage sustained release (SR) vide SO. 1499 (E) dated 30.03.2022, as under-

Sl. No.

Name of

Formulation

Dosage and strength

Unit

Ceiling price in Rs.

561

Metoprolol

Capsule 25mg

I Capsule

4.70

562

Metoprolol

Capsule 50mg

I Capsule

7.16

563

Metoprolol

SR Tablet 25mg

1 Tablet

4.47

564

Metoprolol

SR Tablet 50mg

1 Tablet

6.41

565

Metoprolol

Tablet 25mg

1 Tablet

3.46

566

Metoprolol

Tablet 50mg

1 Tablet

5.24

The National Pharmaceutical Pricing Authority (NPPA) has recognized that plain conventional Metoprolol tablets are distinct from sustained-release (SR) and extended-release (ER) formulations by setting separate ceiling prices for each, as outlined in Schedule-I of the National List of Essential Medicines (NLEM, 2015), the petitioner stated, adding that pricing for controlled-release formulations should only be considered if explicitly listed.

It referred to the Hon'ble Supreme Court, in a 2019 ruling, that acknowledged the DPCO's awareness of different drug delivery systems, noting that modifications in drug release can enhance stability, safety, and efficacy. The Court defined "sustained release" as a system that maintains a consistent rate of drug release over time. Additionally, the Delhi High Court ruled that price notifications for conventional tablets do not apply to controlled-release formulations.

The pharma firm claimed that it is suffering significant losses due to what it considers arbitrary price fixation in the notification dated January 6, 2023. Therefore, it requested the reviewing authority to withdraw this notification regarding Metoprolol 25mg and 50mg Extended Release formulations or amend it appropriately.

NPPA on the other hand argued that the instant review is not tenable as that the pricing methodology followed was appropriate. According to NPPA, if a modified release variant is not specifically mentioned, both conventional and modified release data could be included in the pricing calculations. This approach aligns with the methodology outlined in the National List of Essential Medicines (NLEM) 2015, which aims to ensure the availability of essential drugs.

The methodology approved and followed for the pricing of MR Variant/Conventional Variant by the Authority read;

"Wherever, MR variant is specifically mentioned in any formulation the data of only MR variants (CR, SR, XL, ER delayed release etc.) may be considered for fixation of ceiling price. However, where MR variant is not specifically mentioned, data of conventional as well as MR variants may be considered for ceiling price fixation. This is in line with methodology of NLEM 2015 also. Similarly, where DT/effervescent/soluble/MD, etc. is specifically mentioned in any formulation in any formulation the data of only such variants may be considered. However, in absence of any variant being specifically mentioned, the DT/ effervescent /soluble/MD may be considered along with conventional form.

It further said that the NLEM is prepared with the objective of satisfying the priority health care needs of the population. The list is made based on disease prevalence, efficacy, safety and comparative cost-effectiveness of the medicines. The aim behind formulating NLEM is to ensure that these medicines are available in adequate quantity, in appropriate dosage forms and strengths with assured quality. NLEM does recognize such innovations in drugs where substantial improvements, effectiveness and efficacy have been introduced either in terms of quality or in the delivery system or both. Accordingly, NLEM mentions such innovative drugs separately under different categories commonly named as Modified Release (MR) versions in the same list where such criteria are fulfilled. When the same is not mentioned separately, then all such varieties of such drugs for the specified dosages are considered to be part of variants appearing in the list. The objective of NLEM, inter alia, is to ensure availability of the essential drugs as well. This objective may be adversely affected by the exclusion of different variants from the NLEM based on criteria such as MR etc., as such exclusion may encourage essential drugs simply moving out of NLEM. This may not be in line with the spirit and purpose of including these drugs in the list of essential medicines in the first instance.

Subsequently, the Department upheld the action of NPPA fixing the ceiling price of Metoprolol Tablet 25mg and Metoprolol Tablet 50mg via order dated 06.01.2023. The Review Application under consideration was accordingly rejected.

ajanta pharmadepartment of pharmaceuticalsnational pharmaceutical pricing authoritymetoprolol tabletmetoprolol 25mgmetoprolol 50mgprice fixationreview applicationnational list of essential medicinesnlem
Farhat Nasim
Farhat Nasim

    Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    National Consensus 2025 on Role of Bisoprolol Across CV Continuum in Women: Top 10 Takeaways

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Relevance of Pioglitazone in Indian T2DM Care Continuum

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    View All

    Journal Club Today

    Study Reveals Why Your Immune System Works Better in Daylight

    Study Reveals Why Your Immune System Works Better in Daylight

    View All

    Health News Today

    Health Bulletin 30/May/2025

    Health Bulletin 30/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok